Browse > Article
http://dx.doi.org/10.5806/AST.2015.28.1.1

Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in dust using liquld chromatography tandem mass spectrometry  

Lee, W.K. (Department of Laboratory Medicine, National Cancer Center)
Kang, S.J. (Department of Laboratory Medicine, National Cancer Center)
Oh, J.E. (Department of Laboratory Medicine, National Cancer Center)
Hwang, S.H. (Department of Laboratory Medicine, National Cancer Center)
Lee, D.H. (Department of Laboratory Medicine, National Cancer Center)
Publication Information
Analytical Science and Technology / v.28, no.1, 2015 , pp. 1-7 More about this Journal
Abstract
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco specific nitrosamine found only in tobacco products. The ability to monitor biomarker concentrations is very important in understanding environmental tobacco smoke (ETS). In this study, an efficient and sensitive method for the analysis of NNK in dust was developed and validated using liquid chromatography tandem mass spectrometry. Dust was collected with filter paper soaked in methanol. The standard solution and dust sample were diluted with 100 mM ammonium acetate and extracted using dichloromethane. Our calibration curves ranged from 25 to $10^4pg/mL$. Excellent linearity was obtained with correlation coefficient values between 0.9996 and 1.0000. The limit of detection (LOD) was 5 pg/mL ($S/N{\geq}3$) and the retention time was 10 min. The limit of quantification (LOQ) was 25 pg/mL, and the acceptance criteria was the rate of 98-103% (80-120% at levels up to $3{\times}LOQ$). The coefficient of variations (CV) was 2.8%. Accuracies determined from dust samples spiked with four different levels of NNK racurves ranged that from 25 to 104 pg/mL. Excellent linearity was obtained between 92.1% and 114%. The precision of the method was acceptable (5% of CV). The recovery rates of the whole analytical procedure at low, medium, and high levels were 105.7-116.5% for NNK. The carry-over effects during LC-MS/MS analysis were not observed for NNK. This manuscript summarizes the scientific evidence on the use of markers to measure ETS.
Keywords
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Environmental tobacco smoke (ETS) Tobacco-specific nitrosamines (TSNAs) LC-MS/MS Dust;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lyon, In 'International Agency for Research on Cancer', Monogr Eval Carcinog Risks Hum, 83, p1-1438, France 2004.
2 W. O. Spitzer, V. Lawrence, R. Dales, G. Hill, M. C. Archer, P. Clark, L. Abenhaim, J. Hardy, J. Sampalis and S. P. Pinfold, Clin Invest Med., 13(1), 17-42 (1990).
3 R. A. Jenkins, M. R. Guerin and B. A. Tomkins, 'The Chemistry of Environmental Tobacco Smoke: Composition and Measurement'. Lewis Publisher, Boca Raton, Florida, 2000.
4 D. Hoffmann, I. Hoffmann and K. El Bayoumy, Chem. Res. Toxico., 14, 767-790 (2001).   DOI   ScienceOn
5 G. E. Matt, P. J. Quintana, H. Destaillats, L. A. Gundel, M. Sleiman, B. C. Singer, P. Jacob III, N. Benowitz, J. P. Winickoff, V. Rehan, P. Talbot, S. Schick, J. Samet, Y. Wang, B. Hang, M. MartinsGreen, J. F. Pankow and M. F. Hovell, Environ Health Perspect, 119, 1218-26 (2011).   DOI   ScienceOn
6 Lyon, In 'International Agency for Research on Cancer', Monogr Eval Carcinog Risks Hum, 37, p1-291, France, 1985.
7 J. M. Yuan, W. P. Koh, S. E. Murphy, Y. H. Fan, R. W. Wang, S. G. Carmella, S. M. Han, K. Wickham, Y. T. Gao, M. C. Yu and S. S. Hecht, Cancer Res., 69, 2990-2995 (2009).   DOI   ScienceOn
8 S. S. Hecht, Chem. Res. Toxicol., 11, 559-603 (1998).   DOI   ScienceOn
9 A. Burton, Environ Health Perspect, 119, A70-4 (2011).   DOI   ScienceOn
10 J. P. Winickoff, J. Friebely, S. E. Tanski, C. Sherroda, G. E. Matt, M. F. Hovell and R. C. McMillen, Pediatrics, 123, e74-9 (2009).   DOI   ScienceOn
11 M. W. Seong, J. S. Moon, J. H. Hwang, H. J. Ryu, S. J. Kang, S. Y. Kong, T. H. Um, J. G. Park, J. S. Lee and D. H. Lee, Clinica Chimica Acta, 411(1-2), 72-76 (2010).   DOI   ScienceOn
12 L. Gatzke-Kopp and T. Beauchaine, Child Psychiatry Hum Dev, 38, 255-69 (2007).   DOI
13 C.-J. Hsieh, S.-F., Jeng, Y.-N. Su, H.-F. Liao, W.-S. Hsieh, K.-Y. Wu and P.-C. Chen, Nicotine Tob Res., 12, 1108-1117 (2010).   DOI   ScienceOn
14 J. Makin, P. A. Fried and B. Watkinson, Neurotoxicol Teratol., 13, 5-12 (1991).   DOI   ScienceOn
15 S. H. Hwang, J. H. Hwang, J. S. Moon and D. H. Lee, Korean J Pediatr, 55(2), 35-41 (2012)   DOI   ScienceOn
16 D. P. Strachan and D. G. Cook, Thorax, 52, 905-14 (1997).   DOI
17 D. G. Cook and D. P. Strachan, Thorax, 52, 1081-94 (1997).   DOI
18 D. G. Cook, D. P. Strachan and I. M. Carey, Thorax, 53, 884-93 (1998).   DOI
19 G. E. Matt, P. J. E. Quintana, M. F. Hovell, J. T. Bernert, S. Song, N. Novianti, T. Juarez, J. Floro, C. Gehrman, M. Garcia and S. Larson, Tob Control, 13, 29-37 (2004).   DOI
20 N. Ramirez, M. Z. Ozel, A. C. Lewis, R. M. Marce, F. Borrull, J. F. Hamilton, J. Chromatogr A., 1219, 180-187 (2012).   DOI   ScienceOn
21 Food and Drug Administration, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM070107, Accessed 17.04.09.
22 H. Hongwei, Z. Xiaotao, T. Youngfeng, T. Gangling, L. Yulan, H. Qingyuan, Tian Youngfeng, Tang Gangling, Liu Yulan and Hu Qingyuan, J. Pharm. Biomed. Anal, 63, 17-22 (2012).   DOI   ScienceOn